Sign in
BPTH Stock Price, Chart, Stats & News
Bio-Path Holdings, Inc.
Save
Bio-Path Holdings, Inc. (BPTH) does not currently pay a dividend.
379,291
Market cap
–
Current P/E
84.75x
Forward P/E
BPTH chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Bio-Path Holdings, Inc. is a U. S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone.
Similar securities
Based on sector and market capitalization
Report issue